DEPO-MEDROL® Multi-dose Vial Description
(methylprednisolone acetate injectable suspension, USP)
DESCRIPTION
DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL, 40 mg/mL, 80 mg/mL.
Each mL of these preparations contains:
Methylprednisolone acetate | 20 mg | 40 mg | 80 mg |
Polyethylene glycol 3350 | 29.5 mg | 29.1 mg | 28.2 mg |
Polysorbate 80 | 1.97 mg | 1.94 mg | 1.88 mg |
Monobasic sodium phosphate | 6.9 mg | 6.8 mg | 6.59 mg |
Dibasic sodium phosphate USP | 1.44 mg | 1.42 mg | 1.37 mg |
Benzyl alcohol added as a preservative | 9.3 mg | 9.16 mg | 8.88 mg |
Sodium Chloride was added to adjust tonicity.
When necessary, pH was adjusted with sodium hydroxide and/or hydrochloric acid.
The pH of the finished product remains within the USP specified range (e.g., 3.5 to 7.0).
The chemical name for methylprednisolone acetate is pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-,(6α,11ß)- and the molecular weight is 416.51. The structural formula is represented below:
DEPO-MEDROL Sterile Aqueous Suspension contains methylprednisolone acetate which is the 6-methyl derivative of prednisolone. Methylprednisolone acetate is a white or practically white, odorless, crystalline powder which melts at about 215° with some decomposition. It is soluble in dioxane, sparingly soluble in acetone, alcohol, chloroform, and methanol, and slightly soluble in ether. It is practically insoluble in water.
Find DEPO-MEDROL® Multi-dose Vial medical information:
Find DEPO-MEDROL® Multi-dose Vial medical information:
DEPO-MEDROL® Multi-dose Vial Quick Finder
Health Professional Information
Description
DESCRIPTION
DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL, 40 mg/mL, 80 mg/mL.
Each mL of these preparations contains:
Methylprednisolone acetate | 20 mg | 40 mg | 80 mg |
Polyethylene glycol 3350 | 29.5 mg | 29.1 mg | 28.2 mg |
Polysorbate 80 | 1.97 mg | 1.94 mg | 1.88 mg |
Monobasic sodium phosphate | 6.9 mg | 6.8 mg | 6.59 mg |
Dibasic sodium phosphate USP | 1.44 mg | 1.42 mg | 1.37 mg |
Benzyl alcohol added as a preservative | 9.3 mg | 9.16 mg | 8.88 mg |
Sodium Chloride was added to adjust tonicity.
When necessary, pH was adjusted with sodium hydroxide and/or hydrochloric acid.
The pH of the finished product remains within the USP specified range (e.g., 3.5 to 7.0).
The chemical name for methylprednisolone acetate is pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-,(6α,11ß)- and the molecular weight is 416.51. The structural formula is represented below:
DEPO-MEDROL Sterile Aqueous Suspension contains methylprednisolone acetate which is the 6-methyl derivative of prednisolone. Methylprednisolone acetate is a white or practically white, odorless, crystalline powder which melts at about 215° with some decomposition. It is soluble in dioxane, sparingly soluble in acetone, alcohol, chloroform, and methanol, and slightly soluble in ether. It is practically insoluble in water.
Resources
Didn’t find what you were looking for? Contact us.
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Report Adverse Event
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.